In today’s ever-evolving healthcare landscape, patient adherence to medication is one of the most challenging factors impacting treatment success. Non-adherence continues to undermine clinical outcomes, inflate healthcare costs, and frustrate providers, payers, and pharmaceutical companies alike. This is why adherence programs are so crucial, and RareMed’s Patient Support Programs (PSPs) can play an integral role in improving adherence by offering strategic solutions to bridge the gap between prescriptions and patient behavior.
Why Does Adherence Matter?
Adherence to long-term medication regimens is essential to achieving desired healthcare outcomes as expected by health care providers. Poor adherence can lead to a cascade of negative consequences, including:
-
Worsening of Disease State: When patients do not follow their prescribed treatment plans, their condition can deteriorate, leading to more severe health issues.
-
Increased Hospitalizations: Non-adherence often results in complications that require hospitalization, further burdening the healthcare system.
-
Higher Healthcare Costs: The financial implications of non-adherence are significant, with increased medical visits and interventions leading to substantial costs for both patients and payers.
- Side Effects: Patients who fail to adhere to prescribed medication schedules can experience adverse side effects from improper utilization.
-
Reduced Quality of Life: Patients who do not adhere to their medication regimens may experience a decline in their overall well-being and daily functioning.
RareMed builds adherence programs that help biopharma manufacturers and their patients get the most out of their medications, with an unmatched level of customizability, and backed by the industry’s leading patient management platform: RarePath®..
What is an Adherence Program?
Adherence programs are designed to help patients and caregivers effectively follow their prescribed treatment regimens. These programs integrate education, psychosocial support, and personalized assistance to address the myriad reasons patients may not take their medications as directed. Typically implemented under the direction of pharmaceutical companies through PSPs like RareMed, adherence programs often include:
-
Medication Reminders: Utilizing apps, texts, or calls to remind patients to take their medications can improve adherence significantly.
-
Patient Education: Providing information on the disease and treatment helps patients understand the importance of their medication regimen.
-
Financial Assistance: Offering copay support or financial aid options to alleviate the cost burden, which is a common barrier to adherence.
-
Healthcare Professional Outreach: Engaging pharmacists or nurses to offer personalized support and guidance.
RareMed delivers the highest patient satisfaction scores of any patient support program, consistently delivering NPS scores over 90. RareMed was MMIT’s Patient Choice Award winner for 2025, and has delivered the highest average scores for over three years now.
How Can Patient Support Programs Drive Adherence?
RareMed’s HUB services team is uniquely positioned to drive adherence through industry-leading programs and services. Here’s how we make a difference:
-
Personalized Engagement: Providing one-on-one support from product- or disease state-dedicated teams, educating patients on their disease state, and assisting them in managing side effects are crucial components. Personalized interactions can help patients feel more connected and informed about their treatment.
-
Proactive Outreach: RarePath can deliver automated reminders, texts, and follow-up phone calls to keep patients on track. Identifying missed doses or drop-offs in therapy early can help re-engage patients before they stray too far from their treatment plan.
-
Financial Assistance: RareMed team members can help patients access co-pay cards, foundation support, or Patient Assistance Programs (PAP) to reduce out-of-pocket burden, which often leads to non-compliance.
-
Streamlining Access: RareMed provides unparalleled experience in assisting with insurance hurdles to expedite benefit verifications and prior authorizations to ensure timely access to medication and reduce abandonment rates.
The Strategic Role of Adherence Programs in Healthcare
As the industry shifts toward outcomes-based models and personalized care, RareMed is playing an increasingly strategic role in promoting adherence. By combining operational efficiency with empathetic patient support, RareMed’s patient support programs help ensure that therapies reach their full potential, not just in clinical trials, but in real-world settings.
Adherence programs should no longer be seen as optional; they are essential. These programs play a pivotal role in driving better health outcomes, reducing costs, and maximizing the impact of innovative therapies.
Patient adherence remains a persistent challenge. Even the most innovative therapies can fall short if patients do not follow their prescribed treatment regimens. To address this, manufacturers need to partner with HUB services to design programs that streamline access and provide education and engagement for patients to enhance adherence and improve patient outcomes.
By addressing the barriers to adherence through comprehensive support programs, RareMed and similar organizations can transform the healthcare landscape, ensuring that patients receive the full benefits of their prescribed therapies. Contact RareMed today for more information on how we can help support your program and drive better patient adherence.
About RareMed
RareMed Solutions is the nation’s only concierge patient services provider, focused on rare and complex conditions. RareMed partners with biopharma to transform the lives of patients afflicted with devastating complex conditions by accelerating access to biomedical breakthroughs. RareMed offers case management, co-pay, coupon and financial assistance programs, reimbursement support, nursing support, healthcare professional education, patient adherence & education, and non-commercial pharmacy dispensing services to all fifty states, as well as custom-developed associated support technologies, from its headquarters in Pittsburgh, Pennsylvania and bases across the country.
The company has a breadth of experience developing, transitioning, and maintaining therapy-specific solutions that ensure unparalleled manufacturer & patient satisfaction across a variety of patient services models. RareMed’s undivided complex disease focus, high caliber associates, fully dedicated teams, and sophisticated, AI-integrated RarePath proprietary technology enable it to address the unique needs of complex disease patients. RareMed has been recognized as a top workplace in the nation by USA Today and Newsweek, and consistently sets the benchmark for patient experience according to MMIT patient satisfaction surveys. Visit our website at www.RareMed.com.